Myocardial Extracellular Volume Measured from ECG-Ungated Whole-Body CT Examinations as an Early Biomarker of Chemotherapy-Induced Cardiotoxicity: Preliminary Findings

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

PURPOSE: To evaluate whether myocardial extracellular volume (ECV) could be measured from whole-body CT examinations without electrocardiographic gating in cancer patients before and after the chemotherapy, with the goal to detect early-stage myocardial alterations heralding chemotherapy-induced cardiotoxicity. MATERIAL AND METHODS: Consecutive patients receiving chemotherapy with a high (High-risk group) or low (Low-risk group) risk of cardiotoxicity were retrospectively enrolled. Patients underwent a whole-body CT examination for cancer staging before (CT-I) and after the first chemotherapy cycle (CT-II). Precontrast, arterial phase, and late post-contrast CT-I and CT-II images were analysed using in-house software. Myocardial ECV maps were generated from the combined analysis of precontrast and late post-contrast images, whereas the increase of myocardial and blood densities in arterial phase from basal values were compared to calculate arterial myocardial λ (arterial increase of myocardial density/increase of blood density).RESULTS: The population included 89 patients (mean age 63±14 years): 58 High-Risk and 31 Low-Risk. High-risk patients showed a significant increase of ECV of the interventricular septum, from 32% (31-35%) to 37% (35-39%) (p = 0.0002) and lateral wall, from 30% (27-31) to 32% (29-34) (p = 0.028). In contrast, Low-risk patients showed no significant variation of septal (p = 0.16) and LV lateral wall ECV (p = 0.93). Arterial myocardial λ at CT-II was reduced compared to CT-I in 31% of High-risk patients vs 10% of Low-risk patients (p=0.036).CONCLUSION: This preliminary study demonstrated that myocardial ECV can be effectively measured in ECG-ungated whole-body CT examinations for cancer staging in patients undergoing chemotherapy. Potentially cardiotoxic chemotherapy can be associated with alterations of ECV and arterial myocardial λ.

Article activity feed